InMed Pharmaceuticals Inc. Common Shares
$1.39
$0.11 (+8.59%)
$1.32Day Range$1.51
Key Statistics
Market Cap
$7.03M
Shares Outstanding
5.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 10, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$1.49
Day High
$1.51
Day Low
$1.32
Volume
317.2K
VWAP
$1.39
Prev Close
$1.28
Transactions
--
Acc. Volume
--
About InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
PHARMACEUTICAL PREPARATIONSSIC 28346 employeesC/O NORTON ROSE FULBRIGHT CANADA LLP, VANCOUVER, V6B 0M3(604) 669-7207IPO Nov 10, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001728328
- Composite FIGI
- BBG000BT4589
- Share Class FIGI
- BBG001SDV3N2
- Ticker Root
- INM
- SIC Code
- 2834
About InMed Pharmaceuticals Inc. Common Shares (INM) Stock
InMed Pharmaceuticals Inc. Common Shares (INM) closed the 2026-09-17 session at $1.39, up 8.59% versus the previous close (+0.11). The stock opened at $1.49 and traded between $1.32 and $1.51 during that session. Session trading volume was 317K shares. The volume-weighted average price (VWAP) is $1.39.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
InMed Pharmaceuticals Inc. Common Shares has a market capitalization of $7.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. INM is listed on the XNAS exchange. The company employs approximately 6 people. The recorded listing date is 2020-11-10.
On this page you can find market INM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.